Current views on lipid metabolism: statin-induced myopathy

LL Teichmann, M Fleck - Zeitschrift für Rheumatologie, 2010 - Springer
Kardiovaskuläre Erkrankungen sind die häufigste Todesursache in Deutschland, ihre
Prävalenz ist bei Patienten mit entzündlichen rheumatischen Erkrankungen erhöht. Zur …

Statin treatment and exercise: Is there an additive anti-inflammatory effect?

PM Coen - 2008 - search.proquest.com
Purpose. When administered separately, statin treatment and exercise training have anti-
inflammatory effects. The purpose of this study was to determine the effect of combined …

Ipercolesterolemia familiare: dal genotipo al fenotipo ed implicazione terapeutiche dei nuovi farmaci biologici ipocolesterolemizzanti

P Bigolin - 2018 - research.unipd.it
RIASSUNTO INTRODUZIONE e SCOPI dello STUDIO: L'Ipercolesterolemia Familiare (FH) è
un disordine del metabolismo lipidico su base genetica, rara in omozigosi (1/250000) ma …

[引用][C] 2016 ESC/EAS Preporuke za lečenje dislipidemija

MT Cooney - European Heart Journal, 2016

[PDF][PDF] Muscle and Tendon related Adverse Event Prevalence and Incidence Rates with Statin Use

S Mehrotra, K Kim, DM Liebovitz - 2013 - mcs.anl.gov
Muscle and Tendon related Adverse Event Prevalence and Incidence Rates with Statin Use
Page 1 1 Muscle and Tendon related Adverse Event Prevalence and Incidence Rates with …

A Re-assessment of the Risk: Benefit Analysis of Statin Therapy during Pregnancy: Do Benefits of Treatment Outweigh Putative Reproductive Risks.

J Zarek - 2012 - library-archives.canada.ca
An animal model has implicated elevated levels of tissue factor (TF), and resultant
hypercoagulability and inflammation, as key factors in recurrent pregnancy loss (RPL) and …

Lipidstoffwechsel aktuell: statininduzierte Myopathien.

LL Teichmann, M Fleck - Zeitschrift für Rheumatologie, 2010 - search.ebscohost.com
English Cardiovascular diseases are the most common causes of death in Germany and the
prevalence is increased in patients with inflammatory rheumatic diseases. Statins are often …

[PDF][PDF] Le nuove dimensioni della terapia con statine nella prevenzione cardiovascolare

C Vigorito, C Chieffo - Monaldi Arch Chest Dis, 2009 - pdfs.semanticscholar.org
Figura 1.-Trials con statine nei vari profili di rischio cardiovascolare mg/die, e soprattutto nel
PROVE-IT [13] che confrontava atorvastatina 80 mg/die vs pravastatina 40 mg/die. Una meta …

Die JUPITER-Studie: Antworten und Fragen?

F Post, T Münzel - Kardiologie up2date, 2009 - thieme-connect.com
Over the last years the indication for a therapy with statins has been expanded. The recently
published JUPITER-Trial (Jusfication for the Use of Statins in Prevention: an Intervention …

[PDF][PDF] New paradigm of treatment with statins in cardiovascular prevention

C Vigorito, C Chieffo - Monaldi Archives for Chest Disease, 2009 - monaldi-archives.org
Figura 1.-Trials con statine nei vari profili di rischio cardiovascolare mg/die, e soprattutto nel
PROVE-IT [13] che confrontava atorvastatina 80 mg/die vs pravastatina 40 mg/die. Una meta …